Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR4 | P51679 | 1/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CDC25B | P30305 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | FADS1 | O60427 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 3/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30645474 | 0.91 | TP53 (0.38) | CYP1B1KDM4EALDH1A1SMN1; SMN2KMT2A | |
| SCHEMBL21904623 | 0.91 | TP53 (0.38) | CYP1B1KDM4EALDH1A1SMN1; SMN2KMT2A | |
| SCHEMBL30645487 | 0.90 | ALDH1A1 (0.40) | CCR4CYP1B1KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL18482060 | 0.90 | ALDH1A1 (0.40) | CCR4CYP1B1KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL21972415 | 0.88 | ALDH1A1 (0.41) | CYP1B1KDM4EALDH1A1SMN1; SMN2KMT2A | |
| SCHEMBL21972420 | 0.87 | TP53 (0.36) | CYP1B1KDM4EALDH1A1SMN1; SMN2KMT2A | |
| SCHEMBL21972174 | 0.87 | ADORA3 (0.36) | CCR4CYP1B1KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL21972178 | 0.86 | ADORA3 (0.36) | CYP1B1KDM4EALDH1A1KMT2AMEN1 | |
| SCHEMBL21972421 | 0.85 | RAPGEF4 (0.37) | CYP1B1KDM4EALDH1A1SMN1; SMN2KMT2A | |
| SCHEMBL21972175 | 0.85 | AKR1C3 (0.36) | CYP1B1ALDH1A1SMN1; SMN2HPGDTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230150988-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-05-18 | — | — | US | disclosed |
| US-20230150988-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-05-18 | — | — | US | disclosed |
| US-20200140422-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2020-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200140422-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | CYP1A1, CYP1B1, CHRM1 | CCR4 2733/4885CYP1B1 2/4885KDM4E 3940/4885 |
| US-20230150988-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | CYP1A1, CYP1B1, CHRM1 | CCR4 2733/4885CYP1B1 2/4885KDM4E 3940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.